Regulatory News

Acquisition of ROS Technology

OTAQ plc

("OTAQ", or the "Company")

Acquisition ofROS Technology

OTAQ, the marine technology products and solutions group for the global aquaculture and offshore oil and gas industries, is pleased to announce the acquisition of the trade and assets of ROS Technology Limited("ROS Technology ").

OTAQ has acquired the trade and assets of ROS Technology for a consideration of up to £300,000 to be satisfied from existing cash resources (the "Acquisition"). The Acquisition consideration comprises initial consideration of £225,000 and up to a further £75,000 of deferred consideration, payable in two instalments of £37,500 over the next two years, subject to certain criteria.

For the unaudited year ended 30 June 2020, ROS Technology generated revenues of approximately £312,000 and made a profit before tax of approximately £152,000. As at 30 June 2020, its unaudited gross assets amounted to approximately £196,000.

Commenting on the Acquisition, Phil Newby, Chief Executive at OTAQ, said:

"We are very pleased to welcome Peter back to OTAQ through the acquisition of his business, ROS Technology. Peter is well known to the Directors of OTAQ and has a first-class track record for developing ground breaking technologies. At a time where OTAQ is broadening its product and service portfolio to a global client base looking for competitive advantage in its markets, this is an exciting addition to our research and development capability."

 

Contacts :

OTAQ PLC

Via Walbrook

Alex Hambro, Non-Executive Chairman

 

Phil Newby, Chief Executive Officer

Matt Enright, Chief Financial Officer

 

 

 

Dowgate Capital Ltd (Broker & Adviser)

020 3903 7715

David Poutney/James Serjeant/Nick Chambers

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or O[email protected]

Tom Cooper/Nick Rome/Nicholas Johnson

 0797 122 1972 or 07748 325 236 or 07884 664 686

 

About OTAQ:

OTAQ is a highly innovative marine technology company focused on the marineaquaculture, offshore energy, renewables and oceanographic researchsectors. It has 42 employees in four worldwide locations: Lancaster, Aberdeen and Ulverston in the UK and Puerto Montt in Chile. OTAQ'smarine technologyportfolio includes a market-leading intelligent acoustic deterrent system, designed to protect marine-based aquaculture sites from predation, with multiple systems deployed in Scotland, Chile, Finland and Russia.

 

The Oceansense  leak detection systems have a global reputation as the industry standard solution and have been deployed successfully on hundreds of jobs. The Dragonfish laser measurement system is fast becoming recognised as one of the most accurate underwater precision laser measurement systems available. OTAQ also has significant experience in the design & manufacture of underwater connectors, penetrators & communication systems.

 

It seeks to develop and continuously improve its products using its specialist mechanical, electronic and software engineers with decades of experience in bringing underwater technology products to market.

 

OTAQ is proud to be fully ISO 9001;2015 accredited through DNV-GL. ISO 9001 is an internationally recognised quality management system and demonstrates OTAQ's commitment to consistency, continual improvement and customer satisfaction. The certification also demonstrates its ability to consistently deliver products and services to market whilst meeting statutory and regulatory requirements by applying an effective quality management system.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END